PREVALENCEOF EXTENDED SPECTRUM β LACTAMASES (ESBL) IN NON-FERMENTING GRAM NEGATIVE BACILLI FROM CLINICAL ISOLATES.

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2014, Vol 3, Issue 2

Abstract

Background and Objectives: Non fermenting gram negative bacilli (NFGNB) producing Extended spectrum β lactamases (ESBL) are an increasing cause of concern in the hospitals as they produce a therapeutic dilemma for the treating physician. The present study was undertaken to know the prevalence of ESBL producing non fermenting gram negative bacilli from clinical isolates and their antibiotic resistance pattern. Methods: A total of 389 non fermenting gram negative bacilli were recovered from various clinical specimens. All the samples were processed for routine bacterial culture and antimicrobial susceptibility test as per standard protocol. They were further subjected to ESBL production detection by phenotypic confirmatory double disk diffusion test using ceftazidime with and without clavulanic acid. Results: A total of 199(51.15%) isolates were found to be Extended spectrum β-lactamase producers. Majority of Acinetobactercalcoaciticus-baumaniicomplex 80 (80.8%) were ESBL producer where as 114(41.6%) of Pseudomonas aeruginosaisolates were found to be ESBLproducers. ESBL producing organisms were more drug resistant compared to ESBL non producers; Conclusion: The prevalence of ESBL was 51.15% among NFGNB. Significantly higher resistance rate was observed by these isolates to almost all the drugs routinely used.

Authors and Affiliations

Thipperudraswamy . T*| Assistant Professor, Department of Microbiology, Basaveshwara Medical College & Hospital Chitradurga, Karnataka, India, Sudhindra. K. S| Associate Professor, Department of Microbiology, Basaveshwara Medical College & Hospital, Chitradurga, Karnataka, India, Shobha Nadigar| Professor and Head, Department of Microbiology, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India, Mahesh Kumar| Assocate Professor, Department of Microbiology, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India

Keywords

Related Articles

UTILIZATION PATTERN AND MEDICATION ADHERENCE OF ORAL ANTI-DIABETIC MEDICATIONS AMONG TYPE 2 DIABETES MELLITUS PATIENTS IN RURAL AREAS OF KARNATAKA, SOUTH INDIA.

Objective: To assess the utilization pattern and medication Adherence of oral anti-diabetic medications among patients with type 2 diabetes mellitus in rural areas of Bangalore East. Methodology: A prospective observatio...

Prescribing Pattern of Antibiotics in Intensive Care Unit of a Tertiary Care Teaching Hospital

Antibiotics are the most commonly administered drugs in ICU. By optimizing the use of antibiotics within ICU, patient outcomes are improved, better initial antibiotics administration is provided, and the chance of furthe...

FREQUENCY OF HEPATITIS E VIRUS AMONG RENAL TRANSPLANT RECIPIENTS PATIENTS IN KHARTOUM - SUDAN

Background: Renal transplant recipients are known to be susceptible to viral infections, with more severe clinical presentations compared to healthy persons. Hepatitis E virus (HEV) is generally a self-limited disease,...

Impact of High EGCG Consumption on Mouse Liver

Tea is one of the most popular beverages especially among Middle East countries. Epigallocatechin 3-gallate (EGCG), the principal component of green tea is known to have many beneficial effects in therapeutic doses. Howe...

MOLECULAR CHARACTERIZATION OF THE 16S RRNA GENE OF HELICOBACTER PYLORI ISOLATED FROM STOMACH BIOPSY IN GASTRITIS PATIENTS

Background: Helicobacter pylori is now accepted as the most important cause of gastritis in human. There is a growing body of literature on the detection of H. pylori 16S gene in gastritis patients. The study was aimed...

Download PDF file
  • EP ID EP2424
  • DOI -
  • Views 330
  • Downloads 23

How To Cite

Thipperudraswamy . T*, Sudhindra. K. S, Shobha Nadigar, Mahesh Kumar (2014). PREVALENCEOF EXTENDED SPECTRUM β LACTAMASES (ESBL) IN NON-FERMENTING GRAM NEGATIVE BACILLI FROM CLINICAL ISOLATES.. Journal of Biomedical and Pharmaceutical Research, 3(2), 72-79. https://europub.co.uk/articles/-A-2424